International Stem Cell (ISCO) Gross Profit (2010 - 2026)
International Stem Cell (ISCO) posted quarterly Gross Profit of $1.1 million for Q4 2025, down 25.21% year-over-year from $1.5 million in Q4 2024, and down 17.56% quarter-over-quarter from $1.3 million in Q3 2025.
International Stem Cell (ISCO) Gross Profit (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Gross Profit for 16 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Gross Profit fell 25.21% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $5.1 million (down 4.77% YoY), while the FY2025 annual figure was $5.1 million, down 4.77% from the prior year.
- Gross Profit eased to $1.1 million in Q4 2025 per ISCO's latest filing, from $1.3 million in the prior quarter.
- Across five years, Gross Profit topped out at $1.5 million in Q2 2025 and bottomed at $1.0 million in Q3 2022.
- Historically, Gross Profit has averaged $1.2 million across 5 years, with a median of $1.2 million in 2023.
- Annual changes were most pronounced in 2021 — Gross Profit sank 30.61% — and 2024, when it surged 41.91%.
- International Stem Cell's Gross Profit stood at $1.1 million in 2021, then grew by 16.79% to $1.3 million in 2022, then retreated by 20.71% to $1.0 million in 2023, then soared by 41.91% to $1.5 million in 2024, then declined by 25.21% to $1.1 million in 2025.
- Business Quant data shows ISCO's Gross Profit at $1.1 million in Q4 2025, $1.3 million in Q3 2025, and $1.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | International Stem Cell | 3.76 Mn | 2.67 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.46 Mn |
| Jun 30, 2026 | 1.46 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.03 Mn |
| Dec 31, 2023 | 1.03 Mn |